Results Found (485)
March 16, 2011
Google to sponsor 20 Israeli research projects

The deal’s signing by the Hebrew University of Jerusalem’s Yissum Research Development Company Ltd., Tel Aviv University’s Ramot Ltd. technologytransfer company and the Technion Research and Development Foundation (TRDF Ltd.) was announced...

March 7, 2011
Yissum and Hadasit License Regenerative Polymeric Membrane Implants to...

RegeneCure has successfully completed a preclinical study to determine the safety and efficacy of the implant in animal models that mimic bone loss that creates a gap in the bone as result of trauma or disease and cannot be repaired spontaneously.

March 3, 2011
Cracking crimes with a new DNA technique

A new invention from Israeli scientists looks deeper into DNA to show with certainty whether or not a suspect was at the scene of a crime.

February 28, 2011
We are a Growth Engine for the Israeli Economy

40% of biotech inventions in Israel come from the Hebrew University. Yissum, the company in charge of commercializing the university's patents and translating ideas into profits, makes US$60 from royalties alone. CEO Yaacov Michlin says that...

February 21, 2011
HU researcher fortifies plant genomes by ‘editing’ DNA

The breakthrough technique has been announced by Yissum, the university’s technology transfer company, and Danziger Innovations Ltd., a two-year-old biotechnology firm engaged in the discovery and manufacture of new ways to improve traits in...

January 30, 2011
Yissum, vaxan collaborate on printed electronics ink

Yissum and Korean innovative printing company Vaxan Steel Co. Ltd., signed a licensing and research agreement for the development of silver nanoparticles and silver-coated copper nanoparticles for conductive inks. These inks can be utilized in a...

January 5, 2011
Yissum spin off Novagali Pharma receives positive Scientific Advice from the...

This multicenter, double masked pivotal study, will involve approximately 250 patients. Novagali Pharma expects to obtain regulatory clearance, to initiate this study, before the end of H1 2011. Results are expected to become available by mid 2012

December 21, 2010
Yissum's spin off BioCancell brain cancer preclinical trial successful

The study found that there were delays in the development of Glioblastoma multiforme primary brain cancer tumors in 60% of the rats in the study.


December 19, 2010
Crime investigation: catching criminals- one cell at a time

A new breakthrough in DNA forensic crime scene techniques is set to enable detectives to identify the presence of a specific suspect at a crime scene even if the individual’s DNA is mixed up with that of other people who were present – a capacity...

December 13, 2010
Yissum Introduces a Novel Method for Forensic DNA Profiling

Method enables accurate identification of a suspect's DNA in crime scenes even when DNA evidence comprises a mixture from multiple individuals

December 13, 2010
Yissum Spin-off Morria plans offering on TASE

Morria's drug pipeline is based on innovative anti-inflammatory technology developed at Hebrew University and commercialized through Yissum Technology Transfer Company.

December 7, 2010
Milagro Israeli En Tierra Hostil

El estado hebreo, el país con más ingenieros por kilómetro cuadrado, espera cerrar 2010 con un crecimiento del 4,1% pese al permanente conflicto con sus vecinos y la crisis mundial